Cargando…
Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer’s disease risk in the general population: a Mendelian randomisation study
AIMS/HYPOTHESIS: Metformin use has been associated with reduced incidence of dementia in diabetic individuals in observational studies. However, the causality between the two in the general population is unclear. This study uses Mendelian randomisation (MR) to investigate the causal effect of metfor...
Autores principales: | Zheng, Jie, Xu, Min, Walker, Venexia, Yuan, Jinqiu, Korologou-Linden, Roxanna, Robinson, Jamie, Huang, Peiyuan, Burgess, Stephen, Au Yeung, Shiu Lun, Luo, Shan, Holmes, Michael V., Davey Smith, George, Ning, Guang, Wang, Weiqing, Gaunt, Tom R., Bi, Yufang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477943/ https://www.ncbi.nlm.nih.gov/pubmed/35902387 http://dx.doi.org/10.1007/s00125-022-05743-0 |
Ejemplares similares
-
Efficacy of metformin targets on cardiometabolic health in the general population and non-diabetic individuals: a Mendelian randomization study
por: Zheng, Jie, et al.
Publicado: (2023) -
Mendelian randomization applied to pharmaceutical use: the case of metformin and lung cancer
por: Yarmolinsky, James, et al.
Publicado: (2020) -
Impact of glycemic traits, type 2 diabetes and metformin use on breast and prostate cancer risk: a Mendelian randomization study
por: Au Yeung, Shiu Lun, et al.
Publicado: (2019) -
Examining the possible causal relationship between lung function, COPD and Alzheimer’s disease: a Mendelian randomisation study
por: Higbee, Daniel, et al.
Publicado: (2021) -
Standardizing the reporting of Mendelian randomization studies
por: Au Yeung, Shiu Lun, et al.
Publicado: (2023)